J. P. Durkin

1.3k total citations
37 papers, 1.2k citations indexed

About

J. P. Durkin is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, J. P. Durkin has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in J. P. Durkin's work include Virus-based gene therapy research (5 papers), Neuroscience and Neuropharmacology Research (5 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). J. P. Durkin is often cited by papers focused on Virus-based gene therapy research (5 papers), Neuroscience and Neuropharmacology Research (5 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). J. P. Durkin collaborates with scholars based in Canada, United States and France. J. P. Durkin's co-authors include J. F. Whitfield, Paul Morley, W. Thomas Shier, Balu Chakravarthy, Roger Tremblay, Geoff Mealing, Danica Stanimirovic, Josée Wong, John P. MacManus and Jie Shan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

J. P. Durkin

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. P. Durkin Canada 19 660 219 186 121 100 37 1.2k
Rein Anton United States 7 1.3k 2.0× 356 1.6× 186 1.0× 121 1.0× 93 0.9× 9 1.9k
Michael S. Dobbie United Kingdom 13 441 0.7× 113 0.5× 187 1.0× 207 1.7× 41 0.4× 22 1.1k
Nancy A. Burke United States 10 829 1.3× 211 1.0× 462 2.5× 93 0.8× 210 2.1× 13 1.5k
Harcharan K. Rooprai United Kingdom 19 550 0.8× 92 0.4× 227 1.2× 58 0.5× 105 1.1× 34 1.3k
Gian Nicola Gallus Italy 16 623 0.9× 154 0.7× 144 0.8× 152 1.3× 58 0.6× 26 1.2k
Usha Gundimeda United States 24 888 1.3× 187 0.9× 116 0.6× 116 1.0× 91 0.9× 44 1.9k
Barbara Fischer Germany 19 587 0.9× 87 0.4× 210 1.1× 70 0.6× 78 0.8× 47 1.2k
Fábio A. Mendes Brazil 18 756 1.1× 147 0.7× 117 0.6× 70 0.6× 134 1.3× 32 1.2k
Jaime M. Merino Spain 18 636 1.0× 197 0.9× 109 0.6× 39 0.3× 71 0.7× 41 1.2k
Kouichi Katayama Japan 19 728 1.1× 147 0.7× 82 0.4× 38 0.3× 79 0.8× 57 1.3k

Countries citing papers authored by J. P. Durkin

Since Specialization
Citations

This map shows the geographic impact of J. P. Durkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Durkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Durkin more than expected).

Fields of papers citing papers by J. P. Durkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Durkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Durkin. The network helps show where J. P. Durkin may publish in the future.

Co-authorship network of co-authors of J. P. Durkin

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Durkin. A scholar is included among the top collaborators of J. P. Durkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Durkin. J. P. Durkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cummings, Jeffrey L., Timothy H. Ward, Eric C. LaCasse, et al.. (2005). Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. British Journal of Cancer. 92(3). 532–538. 64 indexed citations
3.
Des̀granges, Claude, Mary‐Anne Trabaud, James F. Whitfield, et al.. (1998). Investigations into the cross‐reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV‐1 gp120 proteins. Journal of Peptide Research. 52(5). 410–420. 23 indexed citations
4.
Stanimirovic, Danica, Rita Ball, & J. P. Durkin. (1997). Glutamate Uptake and Na,K-ATPase Activity in Rat Astrocyte Cultures Exposed to Ischemia. PubMed. 70. 1–3. 7 indexed citations
5.
6.
Durkin, J. P., Roger Tremblay, Alastair M. Buchan, et al.. (1996). An Early Loss in Membrane Protein Kinase C Activity Precedes the Excitatory Amino Acid‐Induced Death of Primary Cortical Neurons. Journal of Neurochemistry. 66(3). 951–962. 49 indexed citations
7.
Yin, Lu, Roger Tremblay, Hervé Jouishomme, Balu Chakravarthy, & J. P. Durkin. (1994). Evidence that the activation of an inactive pool of membrane-associated protein kinase C is linked to the IL-2-dependent survival of T lymphocytes.. The Journal of Immunology. 153(4). 1495–1504. 18 indexed citations
8.
Morley, Paul, Barbara C. Vanderhyden, Roger Tremblay, et al.. (1994). Purinergic receptor-mediated intracellular Ca2+ oscillations in chicken granulosa cells.. Endocrinology. 134(3). 1269–1276. 19 indexed citations
9.
10.
Durkin, J. P., et al.. (1992). Evidence that a novel human differentiation-inhibiting protein blocks the dimethyl sulfoxide-induced differentiation of erythroleukemia cells by inhibiting the activation of membrane protein kinase C.. PubMed. 52(22). 6329–34. 11 indexed citations
11.
Jouishomme, Hervé, J. F. Whitfield, Balu Chakravarthy, et al.. (1992). The protein kinase-C activation domain of the parathyroid hormone.. Endocrinology. 130(1). 53–60. 132 indexed citations
12.
Durkin, J. P., Jean Paul Blanchet, J. F. Whitfield, et al.. (1991). Characterization of a Novel Erythropoiesis‐Inhibiting Human Protein. Annals of the New York Academy of Sciences. 628(1). 233–240. 2 indexed citations
13.
Doyonnas, Régis, Marie‐Jeanne Vacheron, Micheline Guinand, et al.. (1990). The cytotoxicity of Pseudomonas exotoxin A, inactivated by modification of the cell-binding domain I, is restored when conjugated to an erythroid cell-specific targeting agent. Cancer Letters. 50(2). 121–127. 3 indexed citations
14.
Durkin, J. P. & J. F. Whitfield. (1990). Characterization of the mitogenic signal from an oncogene ras protein.. PubMed. 9(5). 1313–23. 9 indexed citations
15.
Fasciotto, Brigitte H., et al.. (1988). Autocrine differentiation-inhibiting factor (ADIF) from chicken erythroleukemia cells acts on human and mouse early BFU-E erythroid progenitors. Biochemical and Biophysical Research Communications. 157(2). 762–769. 5 indexed citations
16.
Durkin, J. P. & J. F. Whitfield. (1987). The viral Ki-ras gene must be expressed in the G2 phase if ts Kirsten sarcoma virus-infected NRK cells are to proliferate in serum-free medium.. Molecular and Cellular Biology. 7(1). 444–449. 12 indexed citations
17.
Durkin, J. P. & J. F. Whitfield. (1986). Characterization of G1 transit induced by the mitogenic-oncogenic viral Ki-ras gene product.. Molecular and Cellular Biology. 6(5). 1386–1392. 32 indexed citations
18.
Durkin, J. P., George V. Pickwell, Joseph Trotter, & W. Thomas Shier. (1981). Phospholipase A2 electrophoretic variants in reptile venoms. Toxicon. 19(4). 535–546. 23 indexed citations
19.
Shier, W. Thomas, Joseph Trotter, & J. P. Durkin. (1979). Poly-L-lysine stimulation of mammalian cell surface phospholipase A2 and prostaglandin synthesis. Federation Proceedings. 38. 1 indexed citations
20.
Durkin, J. P., Gary I. Dmitrienko, & T. Viswanatha. (1977). Reversibility of the ampicillin- and nitrite-induced inactivation of β-lactamase I. Canadian Journal of Biochemistry. 55(4). 453–457. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rein Anton Breakdown of academic impact, for papers by Michael S. Dobbie Breakdown of academic impact, for papers by Nancy A. Burke Breakdown of academic impact, for papers by Harcharan K. Rooprai Breakdown of academic impact, for papers by Gian Nicola Gallus Breakdown of academic impact, for papers by Usha Gundimeda Breakdown of academic impact, for papers by Barbara Fischer Breakdown of academic impact, for papers by Fábio A. Mendes Breakdown of academic impact, for papers by Jaime M. Merino Breakdown of academic impact, for papers by Kouichi Katayama
Rankless by CCL
2026